Notably, studies using glucagon receptor–deficient (GCGR-/-) mouse models have demonstrated that inhibiting glucagon action can ameliorate hyperglycemia even in the absence of insulin (27, 55). The gene discussed is GCG; the disease is Hyperglycemia.